Eager for better migraine therapies: keep your (telcage)PANTs on.

作者: R. B. Lipton , P. S. Sandor

DOI: 10.1212/WNL.0000000000000782

关键词:

摘要: Pharmacologic therapies for migraine have traditionally been divided into 2 broad and distinct categories.1– 3 Acute treatments are given at the time of a attack to relieve pain restore function. Preventive usually taken on daily basis reduce frequency headaches. Conventional wisdom suggests that drugs used as acute (i.e., triptans, ergot alkaloids, nonsteroidal anti-inflammatory agents) differ from preventive (antiepilepsy drugs, β-blockers, calcium channel blockers, antidepressants) in mechanism action, pharmacokinetic profiles, patterns use. Some treatments, particularly opioids barbiturates, if too often, might lead worsening headaches process variously conceptualized transformation, chronification, or development medication overuse headache.4

参考文章(17)
H J Featherstone, Low-dose propranolol therapy for aborting migraine. Western Journal of Medicine. ,vol. 138, pp. 416- 417 ,(1983)
R. Shahien, S. A. Saleh, A. Bowirrat, Intravenous sodium valproate aborts migraine headaches rapidly. Acta Neurologica Scandinavica. ,vol. 123, pp. 257- 265 ,(2011) , 10.1111/J.1600-0404.2010.01394.X
Stephen D. Silberstein, Topiramate in Migraine Prevention Archives of Neurology. ,vol. 61, pp. 490- 495 ,(2004) , 10.1001/ARCHNEUR.61.4.490
Tony W. Ho, Lars Edvinsson, Peter J. Goadsby, CGRP and its receptors provide new insights into migraine pathophysiology Nature Reviews Neurology. ,vol. 6, pp. 573- 582 ,(2010) , 10.1038/NRNEUROL.2010.127
Marcelo E. Bigal, Sarah Walter, Alan M. Rapoport, Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development. Headache. ,vol. 53, pp. 1230- 1244 ,(2013) , 10.1111/HEAD.12179
Jes Olesen, Hans-Christoph Diener, Ingo W. Husstedt, Peter J. Goadsby, David Hall, Ulrich Meier, Stephane Pollentier, Lynna M. Lesko, Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine New England Journal of Medicine. ,vol. 350, pp. 1104- 1110 ,(2004) , 10.1056/NEJMOA030505
K.M.A. Welch, D. J. Ellis, P. A. Keenan, Successful migraine prophylaxis with naproxen sodium Neurology. ,vol. 35, pp. 1304- 1304 ,(1985) , 10.1212/WNL.35.9.1304
Cenk Ayata, Hongwei Jin, Chiho Kudo, Turgay Dalkara, Michael A. Moskowitz, Suppression of cortical spreading depression in migraine prophylaxis Annals of Neurology. ,vol. 59, pp. 652- 661 ,(2006) , 10.1002/ANA.20778